APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrated Multi-Omics Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Integrated Multi-Omics Services Market Analysis and Forecast 2026-2032

1 May 2026226 pages

Choose your research edition.

Industry ResearchIntegrated Multi-Omics Services Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrated Multi-Omics Services Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Integrated Multi-Omics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrated Multi-Omics Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrated Multi-Omics Services Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Integrated Multi-Omics Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Integrated Multi-Omics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Integrated Multi-Omics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Integrated Multi-Omics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Integrated Multi-Omics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Integrated Multi-Omics Services include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient and Bruker Spatial Biology CRO Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Integrated Multi-Omics Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Integrated Multi-Omics Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Integrated Multi-Omics Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Integrated Multi-Omics Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Integrated Multi-Omics Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Integrated Multi-Omics Services revenue, projected growth trends, production technology, application and end-user industry.

Integrated Multi-Omics Services Segment by Company

Azenta Life Sciences

Eurofins

Source BioScience

Psomagen

Tempus

Evotec

Crown Bioscience

Sapient

Bruker Spatial Biology CRO Services

Advanced Cell Diagnostics (ACD)

Panome Bio

RayBiotech

Metware Biotechnology

HaploX

Creative Proteomics

CD Genomics

Omics Empower

Cmbio

Dalton Bioanalytics

General Metabolics

Signios Bio

Source Genomics

Genechem

BGI Genomics

OE Biotech

BMKGENE

Majorbio

Wayen Biotechnologies

Integrated Multi-Omics Services Segment by Type

Dual-Omics Integration Services

Triple-Omics Integration Services

Quadruple & Above Multi-Omics Integration Services

Integrated Multi-Omics Services Segment by Application

Disease Research

Precision Medicine

Crop Breeding

Environmental Microbial Monitoring

Others

Integrated Multi-Omics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Multi-Omics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrated Multi-Omics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Multi-Omics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Integrated Multi-Omics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Integrated Multi-Omics Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrated Multi-Omics Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Integrated Multi-Omics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dual-Omics Integration Services Major Player Table 3. Triple-Omics Integration Services Major Player Table 4. Quadruple & Above Multi-Omics Integration Services Major Player Table 5. Global Integrated Multi-Omics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Disease Research Major Player Table 7. Precision Medicine Major Player Table 8. Crop Breeding Major Player Table 9. Environmental Microbial Monitoring Major Player Table 10. Others Major Player Table 11. Integrated Multi-Omics Services Industry Trends Table 12. Integrated Multi-Omics Services Industry Drivers Table 13. Integrated Multi-Omics Services Industry Opportunities and Challenges Table 14. Integrated Multi-Omics Services Industry Restraints Table 15. Global Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Integrated Multi-Omics Services Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Integrated Multi-Omics Services Market Share by Region (2021-2026) Table 18. Global Integrated Multi-Omics Services Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Integrated Multi-Omics Services Market Share by Region (2027-2032) Table 20. Global Integrated Multi-Omics Services Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Integrated Multi-Omics Services Revenue Market Share by Players (2021-2026) Table 22. Global Integrated Multi-Omics Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Integrated Multi-Omics Services Key Players Headquarters & Area Served Table 24. Global Integrated Multi-Omics Services Players, Product Type & Application Table 25. Global Integrated Multi-Omics Services Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Integrated Multi-Omics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Integrated Multi-Omics Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Integrated Multi-Omics Services Revenue Market Share by Type (2021-2026) Table 32. Global Integrated Multi-Omics Services Revenue Market Share by Type (2027-2032) Table 33. Global Integrated Multi-Omics Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Integrated Multi-Omics Services Revenue Market Share by Application (2021-2026) Table 37. Global Integrated Multi-Omics Services Revenue Market Share by Application (2027-2032) Table 38. Azenta Life Sciences Company Information Table 39. Azenta Life Sciences Business Overview Table 40. Azenta Life Sciences Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio Table 42. Azenta Life Sciences Recent Development Table 43. Eurofins Company Information Table 44. Eurofins Business Overview Table 45. Eurofins Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Eurofins Integrated Multi-Omics Services Product Portfolio Table 47. Eurofins Recent Development Table 48. Source BioScience Company Information Table 49. Source BioScience Business Overview Table 50. Source BioScience Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Source BioScience Integrated Multi-Omics Services Product Portfolio Table 52. Source BioScience Recent Development Table 53. Psomagen Company Information Table 54. Psomagen Business Overview Table 55. Psomagen Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Psomagen Integrated Multi-Omics Services Product Portfolio Table 57. Psomagen Recent Development Table 58. Tempus Company Information Table 59. Tempus Business Overview Table 60. Tempus Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Tempus Integrated Multi-Omics Services Product Portfolio Table 62. Tempus Recent Development Table 63. Evotec Company Information Table 64. Evotec Business Overview Table 65. Evotec Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Evotec Integrated Multi-Omics Services Product Portfolio Table 67. Evotec Recent Development Table 68. Crown Bioscience Company Information Table 69. Crown Bioscience Business Overview Table 70. Crown Bioscience Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Crown Bioscience Integrated Multi-Omics Services Product Portfolio Table 72. Crown Bioscience Recent Development Table 73. Sapient Company Information Table 74. Sapient Business Overview Table 75. Sapient Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Sapient Integrated Multi-Omics Services Product Portfolio Table 77. Sapient Recent Development Table 78. Bruker Spatial Biology CRO Services Company Information Table 79. Bruker Spatial Biology CRO Services Business Overview Table 80. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio Table 82. Bruker Spatial Biology CRO Services Recent Development Table 83. Advanced Cell Diagnostics (ACD) Company Information Table 84. Advanced Cell Diagnostics (ACD) Business Overview Table 85. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio Table 87. Advanced Cell Diagnostics (ACD) Recent Development Table 88. Panome Bio Company Information Table 89. Panome Bio Business Overview Table 90. Panome Bio Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Panome Bio Integrated Multi-Omics Services Product Portfolio Table 92. Panome Bio Recent Development Table 93. RayBiotech Company Information Table 94. RayBiotech Business Overview Table 95. RayBiotech Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. RayBiotech Integrated Multi-Omics Services Product Portfolio Table 97. RayBiotech Recent Development Table 98. Metware Biotechnology Company Information Table 99. Metware Biotechnology Business Overview Table 100. Metware Biotechnology Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Metware Biotechnology Integrated Multi-Omics Services Product Portfolio Table 102. Metware Biotechnology Recent Development Table 103. HaploX Company Information Table 104. HaploX Business Overview Table 105. HaploX Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. HaploX Integrated Multi-Omics Services Product Portfolio Table 107. HaploX Recent Development Table 108. Creative Proteomics Company Information Table 109. Creative Proteomics Business Overview Table 110. Creative Proteomics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Creative Proteomics Integrated Multi-Omics Services Product Portfolio Table 112. Creative Proteomics Recent Development Table 113. CD Genomics Company Information Table 114. CD Genomics Business Overview Table 115. CD Genomics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. CD Genomics Integrated Multi-Omics Services Product Portfolio Table 117. CD Genomics Recent Development Table 118. Omics Empower Company Information Table 119. Omics Empower Business Overview Table 120. Omics Empower Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Omics Empower Integrated Multi-Omics Services Product Portfolio Table 122. Omics Empower Recent Development Table 123. Cmbio Company Information Table 124. Cmbio Business Overview Table 125. Cmbio Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Cmbio Integrated Multi-Omics Services Product Portfolio Table 127. Cmbio Recent Development Table 128. Dalton Bioanalytics Company Information Table 129. Dalton Bioanalytics Business Overview Table 130. Dalton Bioanalytics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio Table 132. Dalton Bioanalytics Recent Development Table 133. General Metabolics Company Information Table 134. General Metabolics Business Overview Table 135. General Metabolics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. General Metabolics Integrated Multi-Omics Services Product Portfolio Table 137. General Metabolics Recent Development Table 138. Signios Bio Company Information Table 139. Signios Bio Business Overview Table 140. Signios Bio Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Signios Bio Integrated Multi-Omics Services Product Portfolio Table 142. Signios Bio Recent Development Table 143. Source Genomics Company Information Table 144. Source Genomics Business Overview Table 145. Source Genomics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Source Genomics Integrated Multi-Omics Services Product Portfolio Table 147. Source Genomics Recent Development Table 148. Genechem Company Information Table 149. Genechem Business Overview Table 150. Genechem Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Genechem Integrated Multi-Omics Services Product Portfolio Table 152. Genechem Recent Development Table 153. BGI Genomics Company Information Table 154. BGI Genomics Business Overview Table 155. BGI Genomics Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. BGI Genomics Integrated Multi-Omics Services Product Portfolio Table 157. BGI Genomics Recent Development Table 158. OE Biotech Company Information Table 159. OE Biotech Business Overview Table 160. OE Biotech Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. OE Biotech Integrated Multi-Omics Services Product Portfolio Table 162. OE Biotech Recent Development Table 163. BMKGENE Company Information Table 164. BMKGENE Business Overview Table 165. BMKGENE Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. BMKGENE Integrated Multi-Omics Services Product Portfolio Table 167. BMKGENE Recent Development Table 168. Majorbio Company Information Table 169. Majorbio Business Overview Table 170. Majorbio Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Majorbio Integrated Multi-Omics Services Product Portfolio Table 172. Majorbio Recent Development Table 173. Wayen Biotechnologies Company Information Table 174. Wayen Biotechnologies Business Overview Table 175. Wayen Biotechnologies Integrated Multi-Omics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio Table 177. Wayen Biotechnologies Recent Development Table 178. North America Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 179. North America Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 180. North America Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 181. North America Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 182. North America Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. North America Integrated Multi-Omics Services Revenue by Country (2021-2026) & (US$ Million) Table 184. North America Integrated Multi-Omics Services Revenue by Country (US$ Million) & (2027-2032) Table 185. Europe Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 186. Europe Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 187. Europe Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Europe Integrated Multi-Omics Services Revenue by Country (2021-2026) & (US$ Million) Table 191. Europe Integrated Multi-Omics Services Revenue by Country (US$ Million) & (2027-2032) Table 192. China Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 193. China Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 194. China Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 195. China Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Integrated Multi-Omics Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Integrated Multi-Omics Services Revenue by Region (US$ Million) & (2021-2026) Table 202. Asia Integrated Multi-Omics Services Revenue by Region (US$ Million) & (2027-2032) Table 203. SAMEA Integrated Multi-Omics Services Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Integrated Multi-Omics Services Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Integrated Multi-Omics Services Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Integrated Multi-Omics Services Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Integrated Multi-Omics Services Revenue by Country (2021-2026) & (US$ Million) Table 209. SAMEA Integrated Multi-Omics Services Revenue by Country (US$ Million) & (2027-2032) Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Integrated Multi-Omics Services Image Figure 2. Global Integrated Multi-Omics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrated Multi-Omics Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dual-Omics Integration Services Image Figure 5. Triple-Omics Integration Services Image Figure 6. Quadruple & Above Multi-Omics Integration Services Image Figure 7. Global Integrated Multi-Omics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Integrated Multi-Omics Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Disease Research Image Figure 10. Precision Medicine Image Figure 11. Crop Breeding Image Figure 12. Environmental Microbial Monitoring Image Figure 13. Others Image Figure 14. Global Integrated Multi-Omics Services Market Size (US$ Million) & (2021-2032) Figure 15. Global Integrated Multi-Omics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Integrated Multi-Omics Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Integrated Multi-Omics Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Integrated Multi-Omics Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Integrated Multi-Omics Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Integrated Multi-Omics Services Revenue Market Share by Type (2021-2032) Figure 22. Global Integrated Multi-Omics Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Integrated Multi-Omics Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Integrated Multi-Omics Services Revenue Market Share by Application (2021-2032) Figure 25. North America Integrated Multi-Omics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Integrated Multi-Omics Services Revenue Share by Type (2021-2032) Figure 27. North America Integrated Multi-Omics Services Revenue Share by Application (2021-2032) Figure 28. North America Integrated Multi-Omics Services Revenue Share by Country (2021-2032) Figure 29. United States Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Integrated Multi-Omics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Integrated Multi-Omics Services Revenue Share by Type (2021-2032) Figure 34. Europe Integrated Multi-Omics Services Revenue Share by Application (2021-2032) Figure 35. Europe Integrated Multi-Omics Services Revenue Share by Country (2021-2032) Figure 36. Germany Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Integrated Multi-Omics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Integrated Multi-Omics Services Revenue Share by Type (2021-2032) Figure 46. China Integrated Multi-Omics Services Revenue Share by Application (2021-2032) Figure 47. Asia Integrated Multi-Omics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Integrated Multi-Omics Services Revenue Share by Type (2021-2032) Figure 49. Asia Integrated Multi-Omics Services Revenue Share by Application (2021-2032) Figure 50. Asia Integrated Multi-Omics Services Revenue Share by Region (2021-2032) Figure 51. Japan Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Integrated Multi-Omics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Integrated Multi-Omics Services Revenue Share by Type (2021-2032) Figure 59. SAMEA Integrated Multi-Omics Services Revenue Share by Application (2021-2032) Figure 60. SAMEA Integrated Multi-Omics Services Revenue Share by Country (2021-2032) Figure 61. Brazil Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Integrated Multi-Omics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Dual-Omics Integration Services
  • Triple-Omics Integration Services
  • Quadruple & Above Multi-Omics Integration Services
Applications
  • Disease Research
  • Precision Medicine
  • Crop Breeding
  • Environmental Microbial Monitoring
  • Others
Companies covered
  • Azenta Life Sciences
  • Eurofins
  • Source BioScience
  • Psomagen
  • Tempus
  • Evotec
  • Crown Bioscience
  • Sapient
  • Bruker Spatial Biology CRO Services
  • Advanced Cell Diagnostics (ACD)
  • Panome Bio
  • RayBiotech
  • Metware Biotechnology
  • HaploX
  • Creative Proteomics
  • CD Genomics
  • Omics Empower
  • Cmbio
  • Dalton Bioanalytics
  • General Metabolics
  • Signios Bio
  • Source Genomics
  • Genechem
  • BGI Genomics
  • OE Biotech
  • BMKGENE
  • Majorbio
  • Wayen Biotechnologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Integrated Multi-Omics Services Market by Type
  3. 1.2.1 Global Integrated Multi-Omics Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dual-Omics Integration Services
  5. 1.2.3 Triple-Omics Integration Services
  6. 1.2.4 Quadruple & Above Multi-Omics Integration Services
  7. 1.3 Integrated Multi-Omics Services Market by Application
  8. 1.3.1 Global Integrated Multi-Omics Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Disease Research
  10. 1.3.3 Precision Medicine
  11. 1.3.4 Crop Breeding
  12. 1.3.5 Environmental Microbial Monitoring
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Integrated Multi-Omics Services Market Dynamics
  1. 2.1 Integrated Multi-Omics Services Industry Trends
  2. 2.2 Integrated Multi-Omics Services Industry Drivers
  3. 2.3 Integrated Multi-Omics Services Industry Opportunities and Challenges
  4. 2.4 Integrated Multi-Omics Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Integrated Multi-Omics Services Market Perspective (2021-2032)
  2. 3.2 Global Integrated Multi-Omics Services Growth Trends by Region
  3. 3.2.1 Global Integrated Multi-Omics Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Integrated Multi-Omics Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Integrated Multi-Omics Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Integrated Multi-Omics Services Revenue by Players
  2. 4.1.1 Global Integrated Multi-Omics Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Integrated Multi-Omics Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Integrated Multi-Omics Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Integrated Multi-Omics Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Integrated Multi-Omics Services Key Players Headquarters & Area Served
  7. 4.4 Global Integrated Multi-Omics Services Players, Product Type & Application
  8. 4.5 Global Integrated Multi-Omics Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Integrated Multi-Omics Services Market CR5 and HHI
  11. 4.6.3 2025 Integrated Multi-Omics Services Tier 1, Tier 2, and Tier 3
5 Integrated Multi-Omics Services Market Size by Type
  1. 5.1 Global Integrated Multi-Omics Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 5.3 Global Integrated Multi-Omics Services Revenue Market Share by Type (2021-2032)
6 Integrated Multi-Omics Services Market Size by Application
  1. 6.1 Global Integrated Multi-Omics Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Integrated Multi-Omics Services Revenue by Application (2021-2032)
  3. 6.3 Global Integrated Multi-Omics Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Azenta Life Sciences
  2. 7.1.1 Azenta Life Sciences Company Information
  3. 7.1.2 Azenta Life Sciences Business Overview
  4. 7.1.3 Azenta Life Sciences Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio
  6. 7.1.5 Azenta Life Sciences Recent Developments
  7. 7.2 Eurofins
  8. 7.2.1 Eurofins Company Information
  9. 7.2.2 Eurofins Business Overview
  10. 7.2.3 Eurofins Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Integrated Multi-Omics Services Product Portfolio
  12. 7.2.5 Eurofins Recent Developments
  13. 7.3 Source BioScience
  14. 7.3.1 Source BioScience Company Information
  15. 7.3.2 Source BioScience Business Overview
  16. 7.3.3 Source BioScience Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Source BioScience Integrated Multi-Omics Services Product Portfolio
  18. 7.3.5 Source BioScience Recent Developments
  19. 7.4 Psomagen
  20. 7.4.1 Psomagen Company Information
  21. 7.4.2 Psomagen Business Overview
  22. 7.4.3 Psomagen Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Psomagen Integrated Multi-Omics Services Product Portfolio
  24. 7.4.5 Psomagen Recent Developments
  25. 7.5 Tempus
  26. 7.5.1 Tempus Company Information
  27. 7.5.2 Tempus Business Overview
  28. 7.5.3 Tempus Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tempus Integrated Multi-Omics Services Product Portfolio
  30. 7.5.5 Tempus Recent Developments
  31. 7.6 Evotec
  32. 7.6.1 Evotec Company Information
  33. 7.6.2 Evotec Business Overview
  34. 7.6.3 Evotec Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Evotec Integrated Multi-Omics Services Product Portfolio
  36. 7.6.5 Evotec Recent Developments
  37. 7.7 Crown Bioscience
  38. 7.7.1 Crown Bioscience Company Information
  39. 7.7.2 Crown Bioscience Business Overview
  40. 7.7.3 Crown Bioscience Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Crown Bioscience Integrated Multi-Omics Services Product Portfolio
  42. 7.7.5 Crown Bioscience Recent Developments
  43. 7.8 Sapient
  44. 7.8.1 Sapient Company Information
  45. 7.8.2 Sapient Business Overview
  46. 7.8.3 Sapient Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sapient Integrated Multi-Omics Services Product Portfolio
  48. 7.8.5 Sapient Recent Developments
  49. 7.9 Bruker Spatial Biology CRO Services
  50. 7.9.1 Bruker Spatial Biology CRO Services Company Information
  51. 7.9.2 Bruker Spatial Biology CRO Services Business Overview
  52. 7.9.3 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio
  54. 7.9.5 Bruker Spatial Biology CRO Services Recent Developments
  55. 7.10 Advanced Cell Diagnostics (ACD)
  56. 7.10.1 Advanced Cell Diagnostics (ACD) Company Information
  57. 7.10.2 Advanced Cell Diagnostics (ACD) Business Overview
  58. 7.10.3 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio
  60. 7.10.5 Advanced Cell Diagnostics (ACD) Recent Developments
  61. 7.11 Panome Bio
  62. 7.11.1 Panome Bio Company Information
  63. 7.11.2 Panome Bio Business Overview
  64. 7.11.3 Panome Bio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Panome Bio Integrated Multi-Omics Services Product Portfolio
  66. 7.11.5 Panome Bio Recent Developments
  67. 7.12 RayBiotech
  68. 7.12.1 RayBiotech Company Information
  69. 7.12.2 RayBiotech Business Overview
  70. 7.12.3 RayBiotech Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 RayBiotech Integrated Multi-Omics Services Product Portfolio
  72. 7.12.5 RayBiotech Recent Developments
  73. 7.13 Metware Biotechnology
  74. 7.13.1 Metware Biotechnology Company Information
  75. 7.13.2 Metware Biotechnology Business Overview
  76. 7.13.3 Metware Biotechnology Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Metware Biotechnology Integrated Multi-Omics Services Product Portfolio
  78. 7.13.5 Metware Biotechnology Recent Developments
  79. 7.14 HaploX
  80. 7.14.1 HaploX Company Information
  81. 7.14.2 HaploX Business Overview
  82. 7.14.3 HaploX Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 HaploX Integrated Multi-Omics Services Product Portfolio
  84. 7.14.5 HaploX Recent Developments
  85. 7.15 Creative Proteomics
  86. 7.15.1 Creative Proteomics Company Information
  87. 7.15.2 Creative Proteomics Business Overview
  88. 7.15.3 Creative Proteomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Creative Proteomics Integrated Multi-Omics Services Product Portfolio
  90. 7.15.5 Creative Proteomics Recent Developments
  91. 7.16 CD Genomics
  92. 7.16.1 CD Genomics Company Information
  93. 7.16.2 CD Genomics Business Overview
  94. 7.16.3 CD Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CD Genomics Integrated Multi-Omics Services Product Portfolio
  96. 7.16.5 CD Genomics Recent Developments
  97. 7.17 Omics Empower
  98. 7.17.1 Omics Empower Company Information
  99. 7.17.2 Omics Empower Business Overview
  100. 7.17.3 Omics Empower Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Omics Empower Integrated Multi-Omics Services Product Portfolio
  102. 7.17.5 Omics Empower Recent Developments
  103. 7.18 Cmbio
  104. 7.18.1 Cmbio Company Information
  105. 7.18.2 Cmbio Business Overview
  106. 7.18.3 Cmbio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Cmbio Integrated Multi-Omics Services Product Portfolio
  108. 7.18.5 Cmbio Recent Developments
  109. 7.19 Dalton Bioanalytics
  110. 7.19.1 Dalton Bioanalytics Company Information
  111. 7.19.2 Dalton Bioanalytics Business Overview
  112. 7.19.3 Dalton Bioanalytics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio
  114. 7.19.5 Dalton Bioanalytics Recent Developments
  115. 7.20 General Metabolics
  116. 7.20.1 General Metabolics Company Information
  117. 7.20.2 General Metabolics Business Overview
  118. 7.20.3 General Metabolics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 General Metabolics Integrated Multi-Omics Services Product Portfolio
  120. 7.20.5 General Metabolics Recent Developments
  121. 7.21 Signios Bio
  122. 7.21.1 Signios Bio Company Information
  123. 7.21.2 Signios Bio Business Overview
  124. 7.21.3 Signios Bio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Signios Bio Integrated Multi-Omics Services Product Portfolio
  126. 7.21.5 Signios Bio Recent Developments
  127. 7.22 Source Genomics
  128. 7.22.1 Source Genomics Company Information
  129. 7.22.2 Source Genomics Business Overview
  130. 7.22.3 Source Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Source Genomics Integrated Multi-Omics Services Product Portfolio
  132. 7.22.5 Source Genomics Recent Developments
  133. 7.23 Genechem
  134. 7.23.1 Genechem Company Information
  135. 7.23.2 Genechem Business Overview
  136. 7.23.3 Genechem Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Genechem Integrated Multi-Omics Services Product Portfolio
  138. 7.23.5 Genechem Recent Developments
  139. 7.24 BGI Genomics
  140. 7.24.1 BGI Genomics Company Information
  141. 7.24.2 BGI Genomics Business Overview
  142. 7.24.3 BGI Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BGI Genomics Integrated Multi-Omics Services Product Portfolio
  144. 7.24.5 BGI Genomics Recent Developments
  145. 7.25 OE Biotech
  146. 7.25.1 OE Biotech Company Information
  147. 7.25.2 OE Biotech Business Overview
  148. 7.25.3 OE Biotech Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 OE Biotech Integrated Multi-Omics Services Product Portfolio
  150. 7.25.5 OE Biotech Recent Developments
  151. 7.26 BMKGENE
  152. 7.26.1 BMKGENE Company Information
  153. 7.26.2 BMKGENE Business Overview
  154. 7.26.3 BMKGENE Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 BMKGENE Integrated Multi-Omics Services Product Portfolio
  156. 7.26.5 BMKGENE Recent Developments
  157. 7.27 Majorbio
  158. 7.27.1 Majorbio Company Information
  159. 7.27.2 Majorbio Business Overview
  160. 7.27.3 Majorbio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Majorbio Integrated Multi-Omics Services Product Portfolio
  162. 7.27.5 Majorbio Recent Developments
  163. 7.28 Wayen Biotechnologies
  164. 7.28.1 Wayen Biotechnologies Company Information
  165. 7.28.2 Wayen Biotechnologies Business Overview
  166. 7.28.3 Wayen Biotechnologies Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio
  168. 7.28.5 Wayen Biotechnologies Recent Developments
8 North America
  1. 8.1 North America Integrated Multi-Omics Services Revenue (2021-2032)
  2. 8.2 North America Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Integrated Multi-Omics Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Integrated Multi-Omics Services Revenue by Type (2027-2032)
  5. 8.3 North America Integrated Multi-Omics Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Integrated Multi-Omics Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Integrated Multi-Omics Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Integrated Multi-Omics Services Revenue by Application (2027-2032)
  9. 8.5 North America Integrated Multi-Omics Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Integrated Multi-Omics Services Revenue by Country
  11. 8.6.1 North America Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Integrated Multi-Omics Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Integrated Multi-Omics Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Integrated Multi-Omics Services Revenue (2021-2032)
  2. 9.2 Europe Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Integrated Multi-Omics Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Integrated Multi-Omics Services Revenue by Type (2027-2032)
  5. 9.3 Europe Integrated Multi-Omics Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Integrated Multi-Omics Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Integrated Multi-Omics Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Integrated Multi-Omics Services Revenue by Application (2027-2032)
  9. 9.5 Europe Integrated Multi-Omics Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Integrated Multi-Omics Services Revenue by Country
  11. 9.6.1 Europe Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Integrated Multi-Omics Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Integrated Multi-Omics Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Integrated Multi-Omics Services Revenue (2021-2032)
  2. 10.2 China Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 10.2.1 China Integrated Multi-Omics Services Revenue by Type (2021-2026)
  4. 10.2.2 China Integrated Multi-Omics Services Revenue by Type (2027-2032)
  5. 10.3 China Integrated Multi-Omics Services Revenue Share by Type (2021-2032)
  6. 10.4 China Integrated Multi-Omics Services Revenue by Application (2021-2032)
  7. 10.4.1 China Integrated Multi-Omics Services Revenue by Application (2021-2026)
  8. 10.4.2 China Integrated Multi-Omics Services Revenue by Application (2027-2032)
  9. 10.5 China Integrated Multi-Omics Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Integrated Multi-Omics Services Revenue (2021-2032)
  2. 11.2 Asia Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Integrated Multi-Omics Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Integrated Multi-Omics Services Revenue by Type (2027-2032)
  5. 11.3 Asia Integrated Multi-Omics Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Integrated Multi-Omics Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Integrated Multi-Omics Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Integrated Multi-Omics Services Revenue by Application (2027-2032)
  9. 11.5 Asia Integrated Multi-Omics Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Integrated Multi-Omics Services Revenue by Country
  11. 11.6.1 Asia Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Integrated Multi-Omics Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Integrated Multi-Omics Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Integrated Multi-Omics Services Revenue (2021-2032)
  2. 12.2 SAMEA Integrated Multi-Omics Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Integrated Multi-Omics Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Integrated Multi-Omics Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Integrated Multi-Omics Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Integrated Multi-Omics Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Integrated Multi-Omics Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Integrated Multi-Omics Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Integrated Multi-Omics Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Integrated Multi-Omics Services Revenue by Country
  11. 12.6.1 SAMEA Integrated Multi-Omics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Integrated Multi-Omics Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Integrated Multi-Omics Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst